Dmitri Kireev is a professor at the University of Missouri with expertise in computer-aided drug design and computational biophysics. The Kireev lab develops and applies computational tools to advance understanding of complex biological systems and discover therapies for unmet medical needs. With ~30 years of expertise spanning industry and academia he has significantly advanced AI-driven drug discovery. Dr. Kireev’s research integrates machine learning with chemical and protein structure to identify high-quality hits for historically intractable targets. His lab developed FRASEbot, an automated AI hit-finding robot, that secured successful performance in three CACHE Challenges, demonstrating the power of his interaction-based discovery strategy. Dr. Kireev has contributed to multiple translational projects and collaborations with academic groups and startup companies. He Professor co-invented kinase-targeted drug candidates, currently in clinical trials, and has authored more than 100 patents and publications.